• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国湿性年龄相关性黄斑变性疾病治疗决策患者体验的定性研究。

Patient experience of treatment decision making for wet age-related macular degeneration disease: a qualitative study in China.

机构信息

Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Amy Medical University), Chongqing, China.

Key Lab of Visual Damage and Regeneration & Restoration of Chongqing, Chongqing, China.

出版信息

BMJ Open. 2019 Sep 3;9(9):e031020. doi: 10.1136/bmjopen-2019-031020.

DOI:10.1136/bmjopen-2019-031020
PMID:31481567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6731856/
Abstract

OBJECTIVES

This study aimed to investigate the experience of patients with wet age-related macular degeneration (wAMD) in treatment decision-making process.

DESIGN

A descriptive qualitative study was designed by using semistructured interviews, and the data analysis was conducted with the thematic analysis approach.

PARTICIPANTS AND SETTING

A convenient and purposive sample of 21 participants diagnosed with wAMD was recruited from May 2018 to September 2018. The study was conducted in the Eye Clinic of Southwest Hospital of Army Medical University in Chongqing located in the southwest of China.

RESULTS

The mean age of the participants was 64.48 years (ranging 50-81 years), and the duration of the disease ranged from 6 months to 48 months. Four major themes were identified from the original data analysis. These themes included facing the darkness (choosing from light and darkness and living in pain), constraints on decision making (doctor-oriented decision making, inadequacy of options and time), weighing alternatives (family influence, financial burden and maintaining social function) and decision-making support (professional decision-making assistance and peer support).

CONCLUSION

This is a qualitative study attempting to explore the patient experience of treatment decision making for wAMD disease in China. Previous literature has focused on treatment effect and symptoms, rather than the individual experience and the wide contexts from a sociocultural perspective. Further studies, such as cross-sectional studies, can be used to describe the status and determine the influencing factors of decision0making process, so as to develop an impact factor model of decision making and to formulate an intervention for patients with wAMD.

摘要

目的

本研究旨在探讨湿性年龄相关性黄斑变性(wAMD)患者在治疗决策过程中的体验。

设计

本研究采用描述性定性研究设计,通过半结构化访谈收集数据,并采用主题分析方法进行数据分析。

参与者和设置

本研究于 2018 年 5 月至 2018 年 9 月,在位于中国西南部的陆军军医大学西南医院眼科,采用便利抽样和目的抽样方法,招募了 21 名被诊断为 wAMD 的患者。

结果

参与者的平均年龄为 64.48 岁(50-81 岁),疾病持续时间为 6 个月至 48 个月。从原始数据分析中确定了四个主要主题。这些主题包括面对黑暗(在光明与黑暗之间做出选择和生活在痛苦中)、决策受限(医生导向的决策、选择不足和时间限制)、权衡选择(家庭影响、经济负担和维持社会功能)和决策支持(专业决策辅助和同伴支持)。

结论

这是一项定性研究,试图探讨中国 wAMD 患者的治疗决策体验。以前的文献主要关注治疗效果和症状,而不是从社会文化角度关注个体体验和广泛的背景。可以进一步开展横断面研究,以描述决策过程的现状并确定影响因素,从而建立决策的影响因素模型,并制定 wAMD 患者的干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c626/6731856/1559e6f51028/bmjopen-2019-031020f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c626/6731856/1559e6f51028/bmjopen-2019-031020f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c626/6731856/1559e6f51028/bmjopen-2019-031020f01.jpg

相似文献

1
Patient experience of treatment decision making for wet age-related macular degeneration disease: a qualitative study in China.中国湿性年龄相关性黄斑变性疾病治疗决策患者体验的定性研究。
BMJ Open. 2019 Sep 3;9(9):e031020. doi: 10.1136/bmjopen-2019-031020.
2
Domains of health-related quality of life in age-related macular degeneration: a qualitative study in the Chinese cultural context.年龄相关性黄斑变性患者健康相关生活质量的维度:中国文化背景下的一项定性研究
BMJ Open. 2018 Apr 17;8(4):e018756. doi: 10.1136/bmjopen-2017-018756.
3
Exploring challenges to nutrition intervention adherence using COM-B model among patients with wet age-related macular degeneration: a qualitative study.利用 COM-B 模型探索湿性年龄相关性黄斑变性患者营养干预依从性的挑战:一项定性研究。
BMJ Open. 2022 Nov 29;12(11):e064892. doi: 10.1136/bmjopen-2022-064892.
4
[Optical Coherence Tomography Angiography-based Follow-up Observation of Wet Age-related Macular Degeneration after Intravitreal Anti-Ranibizumab Therapy].基于光学相干断层扫描血管造影的玻璃体内注射抗雷珠单抗治疗湿性年龄相关性黄斑变性后的随访观察
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019 Jun 30;41(3):359-366. doi: 10.3881/j.issn.1000-503X.10723.
5
Exploring the decision-making experience of elderly diabetes patients regarding their health-seeking behaviour: a descriptive qualitative study.探讨老年糖尿病患者在寻求健康行为方面的决策经验:一项描述性定性研究。
BMJ Open. 2024 Oct 18;14(10):e087126. doi: 10.1136/bmjopen-2024-087126.
6
Experience of Anti-VEGF Treatment and Clinical Levels of Depression and Anxiety in Patients With Wet Age-Related Macular Degeneration.湿性年龄相关性黄斑变性患者抗VEGF治疗经验及抑郁和焦虑的临床水平
Am J Ophthalmol. 2017 May;177:213-224. doi: 10.1016/j.ajo.2017.03.005. Epub 2017 Mar 14.
7
[Availability of resources for patients with wet age-related macular degeneration. Optimal study].[湿性年龄相关性黄斑变性患者的资源可及性。最佳研究]
Arch Soc Esp Oftalmol. 2013 Aug;88(8):307-12. doi: 10.1016/j.oftal.2012.10.009. Epub 2012 Dec 20.
8
Exploring the factors influencing nutritional literacy based on the socioecological model among patients with age-related macular degeneration: a qualitative study from China.基于社会生态学模型探讨年龄相关性黄斑变性患者营养素养的影响因素:来自中国的定性研究。
BMJ Open. 2024 May 28;14(5):e081468. doi: 10.1136/bmjopen-2023-081468.
9
Vision-related quality of life in Japanese patients with wet age-related macular degeneration treated with intravitreal aflibercept in a real-world setting.在真实世界环境中,玻璃体内注射阿柏西普治疗湿性年龄相关性黄斑变性的日本患者的视觉相关生活质量。
Jpn J Ophthalmol. 2019 Nov;63(6):437-447. doi: 10.1007/s10384-019-00687-2. Epub 2019 Oct 31.
10
Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey.湿性年龄相关性黄斑变性(wAMD)治疗的当前障碍:wAMD患者及照料者调查结果
Clin Ophthalmol. 2015 Dec 1;9:2243-50. doi: 10.2147/OPTH.S92548. eCollection 2015.

引用本文的文献

1
Real-world insights of patient voices with age-related macular degeneration in the Republic of Korea and Taiwan: an AI-based Digital Listening study by Semantic-Natural Language Processing.韩国和台湾地区年龄相关性黄斑变性患者声音的真实世界洞察:基于语义自然语言处理的人工智能数字倾听研究
BMC Med Inform Decis Mak. 2025 Mar 18;25(1):137. doi: 10.1186/s12911-025-02929-5.
2
Motivations, psychosocial burdens, and decision-making modes of post-partum women with stress urinary incontinence engaging in pelvic floor physical therapy: a qualitative research.产后压力性尿失禁女性参与盆底物理治疗的动机、心理社会负担和决策模式:一项定性研究。
Int Urogynecol J. 2023 Aug;34(8):1803-1813. doi: 10.1007/s00192-023-05466-9. Epub 2023 Feb 6.
3

本文引用的文献

1
"It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).“感觉就像未竟之事,现在感觉已经结束了”:女性在决定是否进行对侧预防性乳房切除术(CPM)时的体验。
Psychooncology. 2019 Jun;28(6):1328-1334. doi: 10.1002/pon.5086. Epub 2019 Apr 24.
2
Age-related macular degeneration.年龄相关性黄斑变性。
Lancet. 2018 Sep 29;392(10153):1147-1159. doi: 10.1016/S0140-6736(18)31550-2.
3
Domains of health-related quality of life in age-related macular degeneration: a qualitative study in the Chinese cultural context.
Development and Pilot-Testing of a Patient Decision-Making Aid for Nutrition in Age-Related Macular Degeneration.
年龄相关性黄斑变性营养方面患者决策辅助工具的开发与预测试
Patient Prefer Adherence. 2022 Sep 14;16:2567-2577. doi: 10.2147/PPA.S377748. eCollection 2022.
4
Patient participation in treatment decision-making of prostate cancer: a qualitative study.患者参与前列腺癌治疗决策:一项定性研究。
Support Care Cancer. 2022 May;30(5):4189-4200. doi: 10.1007/s00520-021-06753-1. Epub 2022 Jan 27.
5
Shared decision making and patients satisfaction with strabismus care-a pilot study.共同决策和斜视护理患者满意度——一项试点研究。
BMC Med Inform Decis Mak. 2021 Mar 26;21(1):109. doi: 10.1186/s12911-021-01469-y.
年龄相关性黄斑变性患者健康相关生活质量的维度:中国文化背景下的一项定性研究
BMJ Open. 2018 Apr 17;8(4):e018756. doi: 10.1136/bmjopen-2017-018756.
4
Development and pilot-testing of patient decision aid for use among Chinese patients with primary open-angle glaucoma.针对中国原发性开角型青光眼患者的患者决策辅助工具的开发与预测试。
BMJ Open Ophthalmol. 2017 Dec 14;2(1):e000100. doi: 10.1136/bmjophth-2017-000100. eCollection 2017.
5
Comparing Analytic Hierarchy Process and Discrete-Choice Experiment to Elicit Patient Preferences for Treatment Characteristics in Age-Related Macular Degeneration.比较层次分析法和离散选择实验以引出年龄相关性黄斑变性患者对治疗特征的偏好。
Value Health. 2017 Sep;20(8):1166-1173. doi: 10.1016/j.jval.2017.04.022. Epub 2017 May 31.
6
Evaluation of a clinical decision-making aid for nutrition advice in age-related macular degeneration.年龄相关性黄斑变性营养建议临床决策辅助工具的评估
Br J Vis Impair. 2017 Sep;35(3):185-196. doi: 10.1177/0264619616683989. Epub 2017 Aug 23.
7
Prime Time for Shared Decision Making.共同决策的黄金时机。
JAMA. 2017 Apr 4;317(13):1309-1310. doi: 10.1001/jama.2017.0616.
8
Experience of Anti-VEGF Treatment and Clinical Levels of Depression and Anxiety in Patients With Wet Age-Related Macular Degeneration.湿性年龄相关性黄斑变性患者抗VEGF治疗经验及抑郁和焦虑的临床水平
Am J Ophthalmol. 2017 May;177:213-224. doi: 10.1016/j.ajo.2017.03.005. Epub 2017 Mar 14.
9
Nursing actions that create a sense of good nursing care in patients with wet age-related macular degeneration.在湿性年龄相关性黄斑变性患者中营造良好护理感的护理措施。
J Clin Nurs. 2017 Sep;26(17-18):2680-2688. doi: 10.1111/jocn.13749. Epub 2017 Mar 27.
10
Effectiveness of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual non-inferiority trial.社区与医院眼科服务对静止期新生血管性年龄相关性黄斑变性患者的随访效果(ECHoES):一项虚拟非劣效性试验。
BMJ Open. 2016 Jul 8;6(7):e010685. doi: 10.1136/bmjopen-2015-010685.